Binding of active Ras and its mutants to the Ras binding domain of PI-3-kinase: A quantitative approach to KD

Ian R Fleming1, Jonathan P Hannan1, George Hayden Swisher1

  • 1Molecular Biophysics Program and Department of Biochemistry, University of Colorado, Boulder, CO, 80309-0596, USA.

Analytical Biochemistry
|December 16, 2022
PubMed

Insights

Ras mutations can alter binding affinity to PI3K, impacting growth signals. This study quantifies Ras-PI3K binding (KD) using a novel method, revealing mutation-specific effects on this crucial interaction.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Signaling

Background:

  • Ras GTPases are key regulators of cellular signaling pathways.
  • The interaction between Ras and phosphatidylinositol-3-kinase (PI3K) is critical for generating the second messenger phosphatidylinositol-3,4,5-triphosphate (PIP3).
  • Specific Ras mutations are linked to diseases, suggesting altered effector interactions.

Purpose of the Study:

  • To develop and validate a method for quantifying the binding affinity (KD) between active Ras and PI3K.
  • To investigate how Ras mutations at PI3K contact sites affect this binding affinity.
  • To explore the clinical implications of altered Ras-PI3K interactions.

Main Methods:

  • Combined UV spectral deconvolution, High-Performance Liquid Chromatography (HPLC), and microscale thermophoresis.
  • Quantified total Ras concentration and the fraction of active Ras.
  • Measured the binding affinity of active H-Ras and mutants to PI3Kγ Ras-binding domain (RBD) in solution.

Main Results:

  • Developed a precise method for measuring Ras-PI3K binding affinity (KD).
  • Demonstrated that Ras mutations can significantly increase (Q25L), decrease (D38E, Y40C), or have no effect (G13R) on PI3K binding.
  • Showed that quantifying the Ras activation state improves KD measurement accuracy.

Conclusions:

  • Ras mutations can modulate PI3K binding affinity, impacting PIP3 production and downstream signaling.
  • The developed method provides a robust approach to study Ras-effector interactions.
  • Understanding these affinity changes is crucial for deciphering disease mechanisms driven by Ras mutations.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K